FDA Approves Drug for Type 2 Diabetes
Posted on: Friday, 20 October 2006, 18:00 CDT
The U.S. Food and Drug Administration has approved a drug for treating type 2 diabetes that can be used alone or combined with other oral diabetes drugs.
Januvia is the first in a new class of drugs, DPP-IV inhibitors, that assist the body control high blood sugar, the FDA said. The drug may be used alone with diet and exercise. It also could be used with other oral diabetes drugs to lower high blood sugar, when the other drugs, diet and exercise aren't working, the FDA said.
About 14 million people in the United States are diagnosed with diabetes, the FDA said. Type 2 diabetes accounts for between 90 percent and 95 percent of the diagnosed cases.
Januvia works by extending the activity of proteins that support the release of insulin after a rise in blood sugar, the FDA said. The drug blocking an enzyme, DPP-IV, that breaks down these proteins. The proteins can continue their activity longer, which leads to better control of blood sugar levels.
Source: United Press International
Related Articles
- NewCardio Leadership to Make Two Presentations at Drug Information Association Drug Safety Conference
- Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma
- Amrubicin(R) Receives FDA Orphan Drug Designation for the Treatment of Small Cell Lung Cancer
- Research and Markets: Antibiotics and Drug Resistance 2007 - Drug Innovation and the Strategy to Combat Antibiotic Resistance Mechanisms
- All Major National Reference Laboratories Now Offer New GlycoMark Diabetes Blood Test to Complement Hemoglobin A1c Testing in Patients With Diabetes
- FDA Proposes Drug Report Cards
- FDA Approves Drug for Autism Irritability
- Agennix Receives FDA Orphan Drug Designation for Talactoferrin Alfa in Renal Cell Carcinoma
- First Horizon Receives FDA Orphan Drug Designation for Its Glycopyrrolate to Treat Chronic Drooling in Pediatric Patients
- FDA Approves the World's Smallest Diabetes Blood Glucose Monitor
User Comments (0)

RSS Feeds